123 related articles for article (PubMed ID: 8471199)
21. Differences in laboratory values in HIV infection by sex, race, and risk group.
Gorter RW; Vranizan KM; Osmond DH; Moss AR
AIDS; 1992 Nov; 6(11):1341-7. PubMed ID: 1361747
[TBL] [Abstract][Full Text] [Related]
22. Differential effect on serum neopterin and serum beta 2-microglobulin is induced by treatment in Pneumocystis carinii pneumonia.
Benfield TL; Schattenkerk JK; Hofmann B; Jensen BN; Nielsen TL; Lundgren JD
J Infect Dis; 1994 May; 169(5):1170-3. PubMed ID: 8169417
[TBL] [Abstract][Full Text] [Related]
23. Neopterin and beta-2 microglobulin levels in asymptomatic HIV infection: the predictive value of combining markers.
Harrison NA; Skidmore SJ
J Med Virol; 1990 Oct; 32(2):128-33. PubMed ID: 2126281
[TBL] [Abstract][Full Text] [Related]
24. Neopterin and beta 2-microglobulin as serum markers in a placebo-controlled anti-HIV therapy trial.
Carstens J; Teglbjaerg LS; Black FT
Eur J Clin Chem Clin Biochem; 1995 Sep; 33(9):559-62. PubMed ID: 8611664
[TBL] [Abstract][Full Text] [Related]
25. [Lymphocyte subpopulations, neopterin, and beta-2-microglobulin: relationship with clinical stage, risk of progression to AIDS and presence of active infection in HIV infection].
Antón F; Labarga P; Pinilla J; Soto MJ; Leoz A; del Cura J; Borque L; Milazzo A
Enferm Infecc Microbiol Clin; 1993; 11(7):373-7. PubMed ID: 8104488
[TBL] [Abstract][Full Text] [Related]
26. [HIV-1 antigenemia and T-cell activation in HIV-1 infected patients].
Harrer T; Wolf B; Kersten W; Schwarz W; Bergner D; Kalden JR
Klin Wochenschr; 1990 Sep; 68(17):864-8. PubMed ID: 2214610
[TBL] [Abstract][Full Text] [Related]
27. Injecting drug use and HIV infection in southwest China.
Zheng X; Tian C; Choi KH; Zhang J; Cheng H; Yang X; Li D; Lin J; Qu S; Sun X
AIDS; 1994 Aug; 8(8):1141-7. PubMed ID: 7986413
[TBL] [Abstract][Full Text] [Related]
28. Neopterin and beta 2-microglobulin in serum of HIV-seropositive subjects during a two-year follow-up.
Lambin P; Lefrere JJ; Doinel C; Fine JM; Salmon D; Salmon C
Clin Chem; 1988 Jun; 34(6):1367-8. PubMed ID: 3288377
[No Abstract] [Full Text] [Related]
29. Serum beta 2-microglobulin in intravenous drug users and its correlation with human immunodeficiency virus infection.
Chironna M; Fanelli M; Potenza D; Serio G; Quarto M
Int J Clin Lab Res; 1994; 24(2):90-3. PubMed ID: 7919434
[TBL] [Abstract][Full Text] [Related]
30. Decreased plasma concentrations of HDL cholesterol in HIV-infected individuals are associated with immune activation.
Zangerle R; Sarcletti M; Gallati H; Reibnegger G; Wachter H; Fuchs D
J Acquir Immune Defic Syndr (1988); 1994 Nov; 7(11):1149-56. PubMed ID: 7932082
[TBL] [Abstract][Full Text] [Related]
31. Association between neopterin and beta-2-microglobulin levels and HIV status in Romanian orphanage children.
Zaknun D; DiFranco M; Oswald HP; Zaknun J; Mayersbach P; Vuja E; Wachter H; Fuchs D
Wien Klin Wochenschr; 1993; 105(10):284-8. PubMed ID: 8517058
[TBL] [Abstract][Full Text] [Related]
32. 2',5'-oligoadenylate synthetase, neopterin and beta 2-microglobulin in asymptomatic HIV-infected individuals.
Witt PL; Spear GT; Lindstrom MJ; Kessler HA; Borden EC; Phair J; Landay AL
AIDS; 1991 Mar; 5(3):289-93. PubMed ID: 2059368
[TBL] [Abstract][Full Text] [Related]
33. Immune activation markers and AIDS prognosis.
Osmond DH; Shiboski S; Bacchetti P; Winger EE; Moss AR
AIDS; 1991 May; 5(5):505-11. PubMed ID: 1677808
[TBL] [Abstract][Full Text] [Related]
34. Use of beta 2-microglobulin level and CD4 lymphocyte count to predict development of acquired immunodeficiency syndrome in persons with human immunodeficiency virus infection.
Anderson RE; Lang W; Shiboski S; Royce R; Jewell N; Winkelstein W
Arch Intern Med; 1990 Jan; 150(1):73-7. PubMed ID: 1967523
[TBL] [Abstract][Full Text] [Related]
35. Markers of immune stimulation in the cerebrospinal fluid during HIV infection: a longitudinal study.
Gisslén M; Chiodi F; Fuchs D; Norkrans G; Svennerholm B; Wachter H; Hagberg L
Scand J Infect Dis; 1994; 26(5):523-33. PubMed ID: 7855550
[TBL] [Abstract][Full Text] [Related]
36. A prospective study of the association of serum neopterin, beta 2-microglobulin, and hepatitis B surface antigenemia with death in infants and children with HIV-1 disease.
Di Franco MJ; Zaknun D; Zaknun J; Vuja E; Oswald HP; Mayersbach P; Hunter D; Tosteson TD; Trichopoulos D; Schmitzberger R
J Acquir Immune Defic Syndr (1988); 1994 Oct; 7(10):1079-85. PubMed ID: 8083826
[TBL] [Abstract][Full Text] [Related]
37. Elevated neopterin and beta 2-microglobulin levels in blood and cerebrospinal fluid occur early in HIV-1 infection.
Sönnerborg AB; von Stedingk LV; Hansson LO; Strannegård OO
AIDS; 1989 May; 3(5):277-83. PubMed ID: 2504231
[TBL] [Abstract][Full Text] [Related]
38. Predictive markers of AIDS dementia complex: CD4 cell count and cerebrospinal fluid concentrations of beta 2-microglobulin and neopterin.
Brew BJ; Dunbar N; Pemberton L; Kaldor J
J Infect Dis; 1996 Aug; 174(2):294-8. PubMed ID: 8699058
[TBL] [Abstract][Full Text] [Related]
39. Expansion of neopterin and beta 2-microglobulin in cerebrospinal fluid reaches maximum levels early and late in the course of human immunodeficiency virus infection.
Bogner JR; Junge-Hülsing B; Kronawitter U; Sadri I; Matuschke A; Goebel FD
Clin Investig; 1992 Aug; 70(8):665-9. PubMed ID: 1392442
[TBL] [Abstract][Full Text] [Related]
40. Laboratory markers and the risk of developing HIV-1 disease among injecting drug users.
Alcabes P; Selwyn PA; Davenny K; Hartel D; Buono D; Schoenbaum EE; Klein RS; Friedland GH
AIDS; 1994 Jan; 8(1):107-15. PubMed ID: 7912083
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
